In a mouse model of bladder cancer, the 13F3 and TLR3 combination reduced the frequency of the anti-inflammatory macrophages within the tumor and the immunosuppressive transforming growth factor-β1 (TGF-β1) while increasing the CD8+T/Treg ratio (55) exhibiting a high clinical translational potential. This evidence concerns the gene CD8A and neoplasm.